COMPARATIVE CLINICAL EFFECTIVENESS OF AZACITIDINE VERSUS DECITABINE FOR THE FRONT LINE TREATMENT OF ELDERLY ACUTE MYELOID LEUKEMIA (AML) PATIENTS

被引:0
|
作者
Maurillo, L.
Candoni, A.
Spagnoli, A.
Papayannidis, C.
Borlenghi, E.
Lazzarotto, D.
Fianchi, L.
Sciume, M.
Zannier, M. E.
Buccisano, F.
Riva, M.
Breccia, M.
Fanin, R.
Todisco, E.
Lunghi, M.
De Bellis, E.
Fracchiolla, N.
Musto, P.
Venditti, A.
Rossi, G.
机构
[1] Fdn Policlin Tor Vergata, Dipartimento Oncoematol, Rome, Italy
[2] Univ Roma La Sapienza, Azienda Sanit Univ Integrata, Ematol, Rome, Italy
[3] Asst Spedalicivili, Ist Ematol BL&A Seragnoli, Brescia, Italy
[4] Azienda Sanit Univ Integrata, Ematol, Trieste, Italy
[5] Univ Cattolica Sacro Cuore, Ematol, Milan, Italy
[6] Asst Spedalicivili, Brescia, Italy
[7] Univ Tor Vergata, Dipartimento Biomed & Prevenz, Rome, Italy
[8] Osped Niguarda Ca Granda, Ematol, Milan, Italy
[9] Univ Roma La Sapienza, Ematol, Rome, Italy
[10] Azienda Sanit Univ Integrata, Trieste, Italy
[11] Univ Piemonte Orientale, Div Oncoematol IEO, SCDU Ematol, Vercelli, Italy
[12] Fdn IRCCS Ca Granda Osped Maggiore, UO Oncohematol, Milan, Italy
[13] Univ Tor Vergata, Dipartimento Biomed & Prevenz, IRCCS CROB, Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P078
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [41] Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry
    Labrador, Jorge
    la Fuente, Adolfode
    Martinez-Cuadron, David
    Rodriguez-Veiga, Rebeca
    Serrano, Josefina
    Tormo, Mar
    Perez-Simon, Jose
    Ramos, Fernando
    del Castillo, Teresa Bernal
    Lopez-Pavia, Maria
    Trigo, Fernanda
    Sanchez, Pilar Martinez
    Rodriguez-Gutierrez, Juan Ignacio
    Rodriguez, Carlos
    Gil, Cristina
    Garcia, Daniel
    Vives, Susana
    Foncillas, Maria Angeles
    Encinas, Manuel Perez
    Novo, Andres
    Recio, Isabel
    Macias, Gabriela Rodriguez
    Burgues, Juan Miguel Bergua
    Concepcion, Victor Noriega
    Lavilla, Esperanza
    Perez, Alicia Roldan
    Sanz, Miguel A.
    Montesinos, Pau
    BLOOD, 2021, 138
  • [42] Azacitidine Treatment for Pediatric Patients with Acute Myeloid Leukemia
    Kawakami, Ryota
    Isobe, Kiyotaka
    Noguchi, Jun
    Sugawa, Masahiro
    Yanagi, Masato
    Itabashi, Toshikazu
    Mori, Makiko
    Arakawa, Yuki
    Ko, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S68 - S69
  • [43] Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia
    Sadashiv, Santhosh K.
    Hilton, Christie
    Khan, Cyrus
    Rossetti, James M.
    Benjamin, Heather L.
    Fazal, Salman
    Sahovic, Entezam
    Shadduck, Richard K.
    Lister, John
    CANCER MEDICINE, 2014, 3 (06): : 1570 - 1578
  • [44] PATTERNS OF RESCUE TREATMENT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED IN THE FIRST LINE WITH AZACITIDINE AND DECITABIN: RESULTS OF THE PETHEMA AML REGISTRY
    Jorge, Labrador
    David, Martinez-Cuadron
    Adolfo, De la Fuente
    Rebeca, Rodriguez-Veiga
    Josefina, Serrano
    Mar, Tormo
    Jose-Antonio, Perez-Simon
    Fernando, Ramos
    Teresa, Bernal
    Maria, Lopez-Pavia
    Fernanda, Trigo
    Maria-Pilar, Martinez-Sanchez
    Juan-Ignacio, Rodriguez-Gutierrez
    Carlos, Rodriguez-Medina
    Cristina, Gil
    Daniel, Garcia-Belmonte
    Susana, Vives
    Maria-Angeles, Foncillas-Garcia
    Manuel, Perez-Encinas
    Andres, Novo
    Isabel, Recio
    Gabriela, Rodriguez-Macias
    Juan-Miguel, Bergua
    Miguel-Angel, Sanz
    HAEMATOLOGICA, 2021, 106 (10) : 218 - 218
  • [45] Comparative Cost-Effectiveness of Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndromes (MDS)
    Miller, Jeffrey D.
    Fenaux, Pierre
    Beach, C. L.
    Gidwani, Risha
    Khan, Zeba M.
    BLOOD, 2009, 114 (22) : 561 - 561
  • [46] The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
    Valeria Santini
    Michael Lübbert
    Agnieszka Wierzbowska
    Gert J. Ossenkoppele
    Advances in Therapy, 2022, 39 : 1474 - 1488
  • [47] The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia
    Santini, Valeria
    Lubbert, Michael
    Wierzbowska, Agnieszka
    Ossenkoppele, Gert J.
    ADVANCES IN THERAPY, 2022, 39 (04) : 1474 - 1488
  • [48] Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly
    Kuendgen, Andrea
    Germing, Ulrich
    CANCER TREATMENT REVIEWS, 2009, 35 (02) : 97 - 120
  • [49] Venetoclax with Decitabine Versus Decitabine Monotherapy in Elderly Acute Myeloid Leukemia: A Propensity Score Matched Analysis
    Kwag, Daehun
    Bang, Su Yeon
    Lee, Jong Hyuk
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Cho, Byung-Sik
    BLOOD, 2022, 140 : 3214 - 3215
  • [50] Comparison of Azacitidine and Decitabine for the Treatment of Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
    Saiz-Rodriguez, Miriam
    Cuevas, Beatriz
    Martinez-Cuadron, David
    Campuzano, Veronica
    Cuevas, Maria Victoria
    Hermida, Gerardo
    Alvarez, Rodolfo
    Gonzalez-Lopez, Tomas Jose
    Diaz-Galvez, Francisco Javier
    Alcaraz, Raquel
    de Vicente, Pilar
    Sanz, Miguel A.
    Montesinos, Pau
    Labrador, Jorge
    BLOOD, 2020, 136